STTK · Shattuck Labs, Inc.
$6.41
-0.09 (-1.38%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$609.20M
Shares
100.36M
Volume · Oct 5
1.24M
Avg daily vol (3M)
1.2M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.50
Open$6.73
Day$6.30–6.85
52W close$1.77–8.06
Avg vol 30d1.3M
Short int6.8M · 6.8% float · 8.4d
Short vol72%
Last earningsNov 9, 2023
DataOct 2020–Oct 2026
Filing10-Q · Aug 11
Up next
filed Aug 11, 2026
call held Nov 9, 2023
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.00M
Trailing 12 months
Net income (TTM)
−$52.57M
Trailing 12 months
Revenue growth YoY
-82.5%
Year over year
Operating margin
-5,578.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$63.30M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+154.5%
Year over year · more shares
Price change (1Y)
+176.6%
Trailing year
Short interest
6.8%
Latest settlement · 8.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+11%
above
Price vs 50-day avg
−6%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
75%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−4%
trailing
6-month return
−4%
trailing
YTD return
+78%
this year
Relative strength
−16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Flat
2 of 103 funds reported for Sep 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.78% of float · ▲ +22.2% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
103 holders — near 3-yr high, broad support
Squeeze score
76
high risk · 0–100
Fundamentals
Revenue growth
−83%
Y/Y
EPS growth
+53%
Y/Y
Free cash flow
$-40.0M
Quant / Vol
risk profile
Volatility
80%
annualized · 1-yr
Max drawdown
−51%
past year
ATR
6.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+11%
Bullish
Price vs 50-day avg
−6%
Bearish
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
75%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Flat
2 of 103 funds reported for Sep 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
6.78% of float · ▲ +22.2% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
103 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $7 · 75%
Range high $8
vs 200-day avg +11%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
STTK
this stock
Shattuck Labs, Inc.
|
$609.20M | +78.1% | -82.5% | — | 6.8% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$133.37B | +11.1% | +46.2% | 30.7 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.13B | -5.9% | +20.8% | 19.5 | 2.5% |
|
MRNA
Moderna, Inc.
|
$79.40B | +589.1% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$61.25B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| STTK | +1.1% | -4.3% | -4.1% | -4.7% | +78.1% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | -0.1% | -4.9% | -15.7% | -6.3% | +64.5% |